These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1923910)

  • 1. Postinduction carbamazepine clearance in an adult psychiatric population.
    Martin ES; Crismon ML; Godley PJ
    Pharmacotherapy; 1991; 11(4):296-302. PubMed ID: 1923910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Population pharmacokinetics of carbamazepine in adults with epilepsy].
    Romano-Moreno S; Medina-Rojas EL; Salas-Ortiz AL; Vargas-Morales JM; Pérez-Urizar JT; Rodríguez-Leyva I
    Rev Invest Clin; 2005; 57(1):38-48. PubMed ID: 15981957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of lithium.
    Jermain DM; Crismon ML; Martin ES
    Clin Pharm; 1991 May; 10(5):376-81. PubMed ID: 2049899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic model of carbamazepine derived from routine therapeutic drug monitoring data.
    Vucićević K; Miljković B; Velicković R; Pokrajac M; Mrhar A; Grabnar I
    Ther Drug Monit; 2007 Dec; 29(6):781-8. PubMed ID: 18043476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
    Cloyd JC; Marino S; Birnbaum AK
    Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
    Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
    J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
    Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of carbamazepine in psychiatric patients.
    Kanarkowski R; Wankiewicz G; Lehmann W; Rybakowski J
    Pol J Pharmacol Pharm; 1988; 40(1):55-61. PubMed ID: 3237559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in carbamazepine plasma concentrations in psychiatric patients during treatment.
    Kanarkowski R; Rybakowski J; Lehmann W; Matkowski K
    Pol J Pharmacol Pharm; 1991; 43(6):479-85. PubMed ID: 1821043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
    Deleu D; Aarons L; Ahmed IA
    Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules.
    Garnett WR; McLean AM; Zhang Y; Clausen S; Tulloch SJ
    Curr Med Res Opin; 2003; 19(6):519-25. PubMed ID: 14594524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 women.
    Hirt D; Treluyer JM; Jullien V; Firtion G; Chappuy H; Rey E; Pons G; Mandelbrot L; Urien S
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2079-86. PubMed ID: 16723569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures.
    Al Za'abi M; Lanner A; Xiaonian X; Donovan T; Charles B
    Ther Drug Monit; 2006 Dec; 28(6):793-9. PubMed ID: 17164696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin population pharmacokinetic analysis in hospitalized patients.
    Soy D; López E; Ribas J
    Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.